SAN DIEGO & COPENHAGEN, Denmark--(BUSINESS WIRE)--AFYX Therapeutics (“AFYX”), a clinical-stage biopharmaceutical company developing innovative approaches to treat mucosal diseases, announced results ...
Please provide your email address to receive an email when new articles are posted on . In a phase 2, proof-of-concept trial, researchers assessed the safety and efficacy of ZED1227 in the treatment ...
Increased vigilance may be warranted among patients with mucosal damage for future Parkinson disease risk. Patients with a history of upper gastrointestinal (GI) mucosal damage have an increased risk ...
The intestinal immune system plays a pivotal role in maintaining mucosal homeostasis, acting as the interface between environmental stimuli, host epithelial ...
A hamster study found that a COVID vaccine designed to be taken as a pill results in neutralization of the SARS-CoV-2 virus in mucosal tissues. In animal studies that mimic human exposures, an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results